Ginkgo Bioworks Reports Third Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Ginkgo Bioworks (DNA) Misses Q3 EPS by 5c
November 15, 2021 7:38 AM ESTGinkgo Bioworks (NYSE: DNA) reported Q3 EPS of ($0.08), $0.05 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $77.6 million versus the consensus estimate of $45.75 million.
For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.
... More


